
SCYNEXIS Inc. (SCYX) stock Suffers After Hours on New Public Offering Announcement
Shares of the biotechnology company focused on antifungal drugs, SCYNEXIS Inc. (SCYX) suffered a downfall in the after-hours as the company announced a new public
Home » SCYX
Shares of the biotechnology company focused on antifungal drugs, SCYNEXIS Inc. (SCYX) suffered a downfall in the after-hours as the company announced a new public
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.